$GNPX
Genprex Inc

2020 Q1 Form 10-K Financial Statement

#000143774920006522 Filed on March 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 2018 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.090M $8.700M $3.120M
YoY Change 146.39% -23.62% 420.0%
% of Gross Profit
Research & Development $1.478M $1.967M $320.0K
YoY Change 190.9% 102.49% 433.33%
% of Gross Profit
Depreciation & Amortization $5.353K $13.07K $10.00K
YoY Change 82.63% 122.09%
% of Gross Profit
Operating Expenses $1.478M $1.967M $3.440M
YoY Change 190.9% 102.49% 421.21%
Operating Profit -$5.576M -$10.68M
YoY Change 156.88% -13.6%
Interest Expense $10.00K $10.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.570M -$10.65M -$3.430M
YoY Change 157.87% -13.9% 411.94%
Income Tax
% Of Pretax Income
Net Earnings -$5.566M -$10.65M -$3.430M
YoY Change 157.83% -13.88% 411.94%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$199.3K -$664.4K -$227.0K
COMMON SHARES
Basic Shares Outstanding 32.85M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.08M $2.000M $8.600M
YoY Change 232.09% -76.74% 5275.0%
Cash & Equivalents $23.08M $8.601M
Short-Term Investments
Other Short-Term Assets $70.00K $170.0K $240.0K
YoY Change -30.0% -29.17% 1100.0%
Inventory $880.0K $800.0K
Prepaid Expenses
Receivables $0.00 $0.00 $10.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.03M $2.980M $8.847M
YoY Change 240.88% -66.33% 4470.38%
LONG-TERM ASSETS
Property, Plant & Equipment $50.71K $40.00K $24.35K
YoY Change 69.04% 100.0% 212.07%
Goodwill
YoY Change
Intangibles $535.9K $379.5K
YoY Change 37.89% 27.09%
Long-Term Investments
YoY Change
Other Assets $557.7K $20.00K $397.5K
YoY Change 37.76% 0.0% -62.43%
Total Long-Term Assets $608.4K $550.0K $421.9K
YoY Change 42.68% 30.95% -60.42%
TOTAL ASSETS
Total Short-Term Assets $24.03M $2.980M $8.847M
Total Long-Term Assets $608.4K $550.0K $421.9K
Total Assets $24.64M $3.530M $9.269M
YoY Change 229.57% -61.92% 635.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $640.0K $440.0K $300.0K
YoY Change 204.76% 46.67% -52.38%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $70.00K $90.00K
YoY Change -100.0% -22.22% -55.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $697.2K $510.0K $387.8K
YoY Change 201.72% 30.77% -53.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $697.2K $510.0K $387.8K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $700.0K $510.0K $390.0K
YoY Change 204.35% 30.77% -53.01%
SHAREHOLDERS EQUITY
Retained Earnings -$46.05M -$29.82M
YoY Change 43.97% 70.89%
Common Stock $32.85K $15.24K
YoY Change 111.09% 30.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.94M $3.020M $8.881M
YoY Change
Total Liabilities & Shareholders Equity $24.64M $3.530M $9.269M
YoY Change 229.57% -61.92% 635.9%

Cashflow Statement

Concept 2020 Q1 2019 2018 Q4
OPERATING ACTIVITIES
Net Income -$5.566M -$10.65M -$3.430M
YoY Change 157.83% -13.88% 411.94%
Depreciation, Depletion And Amortization $5.353K $13.07K $10.00K
YoY Change 82.63% 122.09%
Cash From Operating Activities -$4.518M -$6.919M -$2.070M
YoY Change 175.16% 1.05% 885.71%
INVESTING ACTIVITIES
Capital Expenditures $11.41K $33.37K -$60.00K
YoY Change 177.6% 48.74%
Acquisitions
YoY Change
Other Investing Activities -$80.00K -$800.0K
YoY Change
Cash From Investing Activities -$137.0K -$946.9K -$60.00K
YoY Change 927.78% 816.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.73M $1.267M
YoY Change -91.77%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.73M 1.267M 420.0K
YoY Change -91.77%
NET CHANGE
Cash From Operating Activities -4.518M -6.919M -2.070M
Cash From Investing Activities -137.0K -946.9K -60.00K
Cash From Financing Activities 25.73M 1.267M 420.0K
Net Change In Cash 21.08M -6.598M -1.710M
YoY Change -1373.45% -178.18% 714.29%
FREE CASH FLOW
Cash From Operating Activities -$4.518M -$6.919M -$2.070M
Capital Expenditures $11.41K $33.37K -$60.00K
Free Cash Flow -$4.529M -$6.952M -$2.010M
YoY Change 175.16% 1.21% 857.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
80882
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33370
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001595248
CY2018Q1 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2018 gnpx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
15385
CY2019 gnpx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
CY2018 gnpx Class Of Warrant Or Right Cancelled During Period Exercise Price
ClassOfWarrantOrRightCancelledDuringPeriodExercisePrice
CY2019 gnpx Class Of Warrant Or Right Cancelled During Period Exercise Price
ClassOfWarrantOrRightCancelledDuringPeriodExercisePrice
CY2018 gnpx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
34615
CY2019 gnpx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
CY2018 gnpx Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
CY2019 gnpx Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
CY2018 gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
1.74
CY2019 gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.47
CY2018 gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
3166492
CY2019 gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
3611504
CY2019Q4 gnpx Investment Unit
InvestmentUnit
0
CY2018Q4 gnpx Investment Unit
InvestmentUnit
0
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32849841
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
30400000
CY2019 dei Entity Registrant Name
EntityRegistrantName
Genprex, Inc.
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2019 dei Trading Symbol
TradingSymbol
gnpx
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018 gnpx Issuance Of Stock For Cash Equity Impact
IssuanceOfStockForCashEquityImpact
15389518
CY2019 gnpx Issuance Of Stock For Cash Equity Impact
IssuanceOfStockForCashEquityImpact
1267194
CY2018Q2 gnpx Nonvoting To Voting Common Stock Conversion Ratio
NonvotingToVotingCommonStockConversionRatio
1
CY2019Q4 gnpx Number Of Patents
NumberOfPatents
34
CY2018Q2 gnpx Operating Lease Rent Expense Per Month
OperatingLeaseRentExpensePerMonth
2050
CY2019 gnpx Payments To Acquire Research And Development Assets
PaymentsToAcquireResearchAndDevelopmentAssets
801780
CY2018 gnpx Payments To Acquire Research And Development Assets
PaymentsToAcquireResearchAndDevelopmentAssets
CY2017Q4 gnpx Percentage Of Outstanding Shares For Warrant To Purchase Shares Of Common Stock
PercentageOfOutstandingSharesForWarrantToPurchaseSharesOfCommonStock
0.03
CY2010 gnpx Proceeds From State Of Texas Emerging Technology Fund Award
ProceedsFromStateOfTexasEmergingTechnologyFundAward
2250000
CY2011 gnpx Proceeds From State Of Texas Emerging Technology Fund Award
ProceedsFromStateOfTexasEmergingTechnologyFundAward
2250000
CY2019Q4 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
801780
CY2018Q4 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
0
CY2010Q4 gnpx State Of Texas Emerging Technology Fund Award Amount
StateOfTexasEmergingTechnologyFundAwardAmount
4500000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
436258
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
295069
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43483740
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38690586
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4882079
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3060396
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3500000
CY2019Q4 us-gaap Assets
Assets
3534229
CY2018Q4 us-gaap Assets
Assets
9268956
CY2019Q4 us-gaap Assets Current
AssetsCurrent
2976643
CY2018Q4 us-gaap Assets Current
AssetsCurrent
8847066
CY2019Q4 us-gaap Cash
Cash
2002492
CY2018Q4 us-gaap Cash
Cash
8600918
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8600918
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161251
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2002492
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6598426
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8439667
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1761278
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
8465768
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.17
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.36
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.45
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
748060
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3864552
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7476056
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
453
CY2019 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
10682673
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15239148
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19263841
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
12363541
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
21732
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19263841
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15239148
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
19264
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
15240
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18085
CY2019 us-gaap Depreciation
Depreciation
13070
CY2018 us-gaap Depreciation
Depreciation
5885
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.90
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4.50
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8702596
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11386229
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
141189
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-443143
CY2018 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-759591
CY2019 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
3647
CY2018 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
18085
CY2019 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-18326
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8642
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
512932
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
397536
CY2018 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-65135
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
213372
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
491200
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
379451
CY2019 us-gaap Interest Expense
InterestExpense
CY2018 us-gaap Interest Expense
InterestExpense
37982
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
27905
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
29184
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3534229
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9268956
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
510684
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
387821
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1267194
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15389518
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-946899
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-103317
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6918721
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6846534
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-10654768
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-12372339
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-10682673
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-12363541
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
16500000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
74426
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
92752
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
111749
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22435
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
171716
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
236851
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1267194
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15389518
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44654
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24354
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
655
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
9297
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1967007
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
971427
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40479459
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29824691
CY2019 us-gaap Revenues
Revenues
CY2018 us-gaap Revenues
Revenues
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3529984
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
5435382
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
127593
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
297058
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
297058
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
127593
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1744300
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2034525
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5982923
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4535681
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.31
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.66
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.21
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.48
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y164D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y270D
CY2019 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
506707
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200009
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
469588
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
553303
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
3023545
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8881135
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
428574
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
6.6841954
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">The preparation of our financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div></div>
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16026980
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13771020

Files In Submission

Name View Source Status
0001437749-20-006522-index-headers.html Edgar Link pending
0001437749-20-006522-index.html Edgar Link pending
0001437749-20-006522.txt Edgar Link pending
0001437749-20-006522-xbrl.zip Edgar Link pending
ex_169590.htm Edgar Link pending
ex_169591.htm Edgar Link pending
ex_169596.htm Edgar Link pending
ex_179342.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnpx-20191231.xml Edgar Link completed
gnpx-20191231.xsd Edgar Link pending
gnpx-20191231_cal.xml Edgar Link unprocessable
gnpx-20191231_def.xml Edgar Link unprocessable
gnpx-20191231_lab.xml Edgar Link unprocessable
gnpx-20191231_pre.xml Edgar Link unprocessable
gnpx20191231b_10k.htm Edgar Link pending
gylze0pdymuz000002.jpg Edgar Link pending
gylze0pdymuz000003.jpg Edgar Link pending
gylze0pdymuz000004.jpg Edgar Link pending
gylze0pdymuz000005.jpg Edgar Link pending
gylze0pdymuz000006.jpg Edgar Link pending
gylze0pdymuz000007.jpg Edgar Link pending
gylze0pdymuz000008.jpg Edgar Link pending
gylze0pdymuz000009.jpg Edgar Link pending
gylze0pdymuz000010.jpg Edgar Link pending
gylze0pdymuz000011.jpg Edgar Link pending
gylze0pdymuz000012.jpg Edgar Link pending
gylze0pdymuz000013.jpg Edgar Link pending
newpipeline800.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending